1. 31LBA MOST – My Own Specific Therapy – A multicenter, randomized, open-label, phase II trial evaluating the clinical benefit of a maintenance treatment targeting tumor molecular alterations in patients with advanced solid tumors: preliminary results from the everolimus and sorafenib cohorts. (September 2015) Authors: Toulmonde, M.; Le Tourneau, C.; Cropet, C.; Italiano, A.; Bertucci, F.; Ray-Coquard, I.; Tredan, O.; Cassier, P.; Seigne, C.; De la Fouchardiere, C.; Flechon, A.; Desseigne, F.; Frappaz, D.; Gomez-Roca, C.A.; Heudel, P.E.; You, B.; Jaouen, L.; Bernardin, M.; Perol, D.; Blay, J.Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study. (24th February 2016) Authors: Trédan, O.; Follana, P.; Moullet, I.; Cropet, C.; Trager-Maury, S.; Dauba, J.; Lavau-Denes, S.; Diéras, V.; Béal-Ardisson, D.; Gouttebel, M.; Orfeuvre, H.; Stefani, L.; Jouannaud, C.; Bürki, F.; Petit, T.; Guardiola, E.; Becuwe, C.; Blot, E.; Pujade-Lauraine, E.; Bachelot, T. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. When local phytotherapies meet biomedicine. Cross-sectional study of knowledge and intercultural practices against malaria in Eastern French Guiana. (28th October 2021) Authors: Odonne, G.; Musset, L.; Cropet, C.; Philogene, B.; Gaillet, M.; Tareau, M.-A.; Douine, M.; Michaud, C.; Davy, D.; Epelboin, L.; Lazrek, Y.; Brousse, P.; Travers, P.; Djossou, F.; Mosnier, E. Journal: Journal of ethnopharmacology Issue: Volume 279(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗